Author: Neel Achary

Senco Gold & Diamonds Unveils ‘Shagun Collection’ Featuring Kiara Advani for Dhanteras

This Dhanteras, Senco Gold & Diamonds launches the ‘Shagun Collection’ with a wholesome Campaign with Kiara Advani

Mumbai, October 15th, 2025 : This Dhanteras, Senco Gold & Diamonds, India’s most trusted jewellery house, unveils the Shagun Collection – a carefully curated range of jewellery in yellow gold, diamond, antique, and polki, designed to add a meaningful touch to festive celebrations. Complementing the signature range are collections for every occasion, from the trendy Lotus Collection by Everlite to the contemporary Tattwa Collection by Gossip Silver and Fashion Jewellery, as well as the men’s Aham Collection and the Hearts & Arrows cut diamond pieces from the Perfect Love Collection.

To mark the launch, Senco Gold & Diamonds brings alive the festivities through a sparkling campaign featuring Kiara Advani. The campaign unfolds as a poetic celebration of togetherness – where every shimmer of gold mirrors the glow of love, and every piece of Senco jewellery becomes a keeper of memories. Set against the luminous backdrop of Diwali and Dhanteras, the narrative brings alive intimate, heartwarming moments shared among families and loved ones – a husband’s surprise, a mother-daughter ritual, a grandmother’s diya tradition. Each story captures the gentle rhythm of festive life, where emotions glisten brighter than the lights themselves.

At the heart of these vignettes is Kiara Advani, as a silent observer – a symbol of Senco’s spirit. She moves gracefully through each frame, connecting one story to another like a golden thread of tradition and affection. Through her eyes, we see how Senco jewellery becomes part of life’s sacred rituals, transforming every gesture of giving into a timeless expression of love and blessings.

Speaking on the launch, Ms. Joita Sen, Director, Head of Marketing and Designs, Senco Gold & Diamonds, said, “Dhanteras is a time of joy, love, and new beginnings—a season that brings families together and turns simple moments into cherished memories. Through the campaign, we wanted to capture the heart of these celebrations – the excitement of giving, the warmth of family traditions, and the meaningful gestures that make this festival so special. The film tells these stories beautifully, showing how Senco jewellery becomes a part of life’s most intimate moments, carrying love, blessings, and memories from one generation to the next. Every piece in the Shagun Collection is crafted with this emotion in mind – true karigari that becomes an important part of the emotions families experience together at festivals.”

Adding to the festive cheer are exciting offers that make this season even more rewarding. Customers can enjoy ₹700–₹1,000 per gram cashback on gold jewellery and up to 15% off on diamond pieces, along with 100% value on old gold exchange. 

PhonePe announces exciting cashback offers on 24K Digital Gold this Dhanteras

October 14, 2025: PhonePe, today announced exciting cashback offers on 24k Digital Gold on the occasion of Dhanteras. Users can avail flat 2% cashback (up to INR 2000) on purchasing a minimum of INR 2000 worth of digital gold from PhonePe. The offer is applicable on October 18, 2025 for one-time transactions only.

Users can purchase 99.99% purity-certified 24K Digital Gold on the PhonePe platform, from leading and trusted players in the digital gold space like MMTC-PAMP, SafeGold and Caratlane. Over 1.6 Crore customers across India have bought high purity 24K gold on the PhonePe platform.

Apart from one time purchase, PhonePe also empowers users to invest in Gold digitally via Daily or Monthly SIPs and helps customers invest long term systematically. Customers also have the flexibility to invest any amount (starting as low as Rs. 5) and sell their gold holdings anytime, with the money credited to their bank accounts.

Here is a step-by-step guide to avail this special cashback offer while buying Gold on PhonePe:

• Click on the ‘Digital Gold’ icon on the PhonePe Homepage.
• Click on ‘Buy Digital Gold’
• Proceed by selecting “Buy in rupees” and add a minimum Rs.2000 worth of 24K Gold
• Check the final details of your Gold purchase and click on ‘Proceed to Pay’, and it’s done.

Offer is valid from 18th October 2025, 00:00 AM to 18th October, 2025, 11:59 PM only on one-time transactions. Minimum order value is Rs. 2000. Valid once per user.

MMRC and Cityflo launch feeder buses to bridge last mile gap for Metro Line 3

Mumbai, 14 october 2025 : The Mumbai Metro Rail Corporation (MMRC) and Cityflo today announced a strategic partnership to introduce dedicated feeder bus services for Mumbai Metro Line 3, with its 3rd phase launched on 8th Oct. The collaboration marks a significant step in addressing one of the city’s most persistent transit challenges of first- and last-mile connectivity, and is expected to play a critical role in driving higher metro adoption across the city.

India’s metro systems have expanded rapidly over the past decade, growing from 248 kilometres across five cities in 2014 to over 1,000 kilometres across 23 cities today. In Mumbai, elevated Metro Lines 2A and 7 have already carried more than 200 million passenger journeys in over 3 years, with daily ridership averaging over 300,000. This type of 1st and last mile commute will further enhance the metro ridership

The MMRC – Cityflo partnership is designed to directly address this friction point. Services will be launched at high-demand stations including Bandra-Kurla Complex (BKC), Worli, and Chhatrapati Shivaji Maharaj Terminus (CSMT), with buses running every 10 minutes during peak hours to ensure minimal waiting time. The initiative will feature integrated ticketing through both the Cityflo app and the Metro Connect 3 app. Over time, deeper integration will allow commuters to book Cityflo feeder services directly within the metro application and vice versa creating a seamless digital journey. Introductory fares are expected to be set at ₹29 per single ride, with a monthly pass option at ₹499 to encourage daily use and build habitual adoption.

Commenting on the partnership, Mr. R. Ramana, Director (Planning & Real Estate Development / NFBR), MMRC, said: “With Metro Line 3, Mumbai is entering a transformative phase in its mobility journey. However, the true success of the metro system will depend on how easily people can access it from their homes to workplaces and back. Through our feeder networks, we are solving this, by ensuring that commuters benefit from a reliable and convenient extension of their metro journey.”

Jerin Venad, CEO, Cityflo added: “We’re excited to partner with MMRC to bring feeder buses to the metro network. This is a natural extension of our mission to make urban commutes frictionless, whether through our direct bus network or by integrating with public transit systems to provide a seamless experience for everyone. Our goal has always been to facilitate a shift from private cars to mass transit, and we’re confident this service will become a catalyst for millions of commuters to embrace a more sustainable way to commute.”

This initiative represents a structural shift in how Mumbai’s transit ecosystem functions, which seeks to unify rail and land urban mobility into a coherent, technology-driven network. By closing the last-mile gap, the partnership aims to improve commuter convenience but also accelerate modal shift away from private vehicles, contributing to reduced congestion and a more sustainable urban environment. 

Hamdard Honey: The Golden Standard of Assured Quality

Delhi, 14 October, 2025: For over a century, Hamdard Foods India has stood for purity, trust, and wellness. At the heart of its portfolio is Hamdard Honey, a product that has become a symbol of natural goodness and health. Carefully sourced from the finest apiaries and processed, Hamdard Honey is packed with the assurance of Quality & Food Safety Standard. making it an everyday refined sugar replacer that fits seamlessly into today’s fast-paced lifestyles.

A natural replacement for refined sugar, Hamdard Honey is more than just a sweetener  it’s a home essential. Whether drizzled over breakfast, stirred into teas, blended into smoothies, or simply consumed with warm water, Hamdard Honey offers a great way to start the day. Backed by stringent quality checks, it ensures every drop has assured quality and trust, true to Hamdard’s uncompromising legacy. 

Speaking about the brand’s focus, Mr. Hamid Ahmed, CEO of Hamdard Foods India, said: “Hamdard Honey represents everything we stand for  quality, trust, and safety  standards. Consumers today are looking for natural alternatives to ultra processed foods, and Hamdard Honey delivers exactly that. It’s not just about taste, it’s about life with the goodness of nature. At Hamdard, we remain committed to bringing products that inspire smart choices without compromise.”

With the association of Aditi Rao Hydari with Hamdard Honey, she strengthens the brand’s legacy and promise with her natural elegance and genuine lifestyle. Aditi embodies the “No Compromise” philosophy, reflecting how purity and quality are non-negotiable when it comes to health and well-being.

Sharing her thoughts, Aditi Rao Hydari said: “For me, wellness is all about simple, pure choices  and Hamdard Honey represents that perfectly. It’s versatile, natural, and something I can trust completely. Whether I use it in my morning routine or in recipes, Hamdard Honey assures me that I’m making the right choice for my health.”

With its blend of trust and innovation, Hamdard Honey continues to inspire families to adopt wiser lifestyles. As the best form of nature’s sweetness, it remains a trusted ally for taste, and well-being  ensuring that when it comes to honey, there is simply no compromise in terms of Quality & Food Safety Standards.

Wholesale Price Inflation Eases to 0.13% in September 2025 as Food and Energy Prices Moderate: PHDCCI

Wholesale Price Index (WPI) data for September 2025 (Provisional), showing that the annual inflation rate stood at 0.13 percent compared to September 2024. On a month-on-month basis, the WPI declined by 0.19 percent, reflecting continued moderation in wholesale price pressures, said Mr. Rajeev Juneja, President, PHDCCI in a press statement issued here today.

The low overall inflation in September was primarily driven by declines in food and primary article prices, even as manufactured product prices showed a mild increase. In the Primary Articles category, prices fell largely due to lower prices of cereals, pulses, vegetables, and non-food articles such as fibres and oilseeds, which is also reflected in CPI for September 2025, he said.

He added the moderation in wholesale prices was mainly due to lower food and energy costs, a strong agricultural output, and stable commodity prices globally. Improved supply-side conditions following a good monsoon, alongside government interventions to check retail prices of essential commodities, also contributed to the decline.

However, the manufactured goods sector continued to witness moderate price rises due to elevated input costs, particularly for raw materials like metals and chemicals, and steady domestic demand in industrial sectors such as cement, steel, and consumer durables, he said.

International crude oil prices showed mild volatility during the month, but remained range-bound, preventing a significant pass-through to domestic fuel inflation. Meanwhile, favourable currency movements and easing global commodity prices (particularly in edible oils and industrial inputs) further reduced cost pressures on producers, he said.

Looking ahead, wholesale inflation is expected to remain benign in the coming months, supported by adequate food supply, stable global commodity prices, and government measures to control inflation in key sectors. The harvest of kharif crops and the expected arrival of rabi produce in the next quarter are likely to keep food inflation contained, says Dr. Ranjeet Mehta, CEO & Secretary General, PHDCCI.

Bristol Myers Squibb Launches Kopozgo for oHCM Treatment in India

Bristol Myers Squibb Launches Kopozgo® (Mavacamten) in India for the treatment of symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Hyderabad, India, October 14, 2025: Bristol Myers Squibb (BMS) today announced the launch of Kopozgo® (Mavacamten) in India. Kopozgo is the first and only oral, selective cardiac myosin inhibitor approved in India for the treatment of adults with symptomatic New York Heart Association (NYHA) Class II–III obstructive hypertrophic cardiomyopathy (oHCM).

Symptomatic obstructive HCM is an often-inherited heart disease that can be a chronic, debilitating and progressive condition where patients may experience symptoms of shortness of breath, dizziness and fatigue as well as serious, life-altering complications, including heart failure, arrhythmias, stroke and in rare cases (~1%) sudden cardiac death. It affects about 1 in 500 people worldwide, and it is estimated that as many as 2.8 million people in India may be living with the condition; however, 80-90 % patients remain undiagnosed.

Existing medical treatments in India, such as beta blockers, calcium channel blockers, and disopyramide, reduce symptoms but do not address the underlying cause. Invasive surgical procedures, including septal reduction therapy (alcohol septal ablation or myectomy), are options but may not be suitable or available for all patients. Additionally, these procedures require substantial operator and surgical expertise. Therefore, medical management of oHCM remains a major unmet need.

Kopozgo is the firstin-class disease-specific treatment targeting the core pathophysiological mechanism of obstructive HCM, leading to improvement in functional capacity of heart and symptoms. 

Mavacamten was approved by the Central Drugs Standard Control Organisation (CDSCO) with an import license issued on March 6, 2025. Kopozgo is now available to patients in India. The approval of Kopozgo in India is based on positive efficacy and safety results from two Phase III clinical trials, EXPLORER-HCM and VALOR-HCM. 

Sanjay Sharma, General Manager and Managing Director, BMS India, mentioned, “With the launch of Kopozgo in India, patients with oHCM now have a promising first-in-class treatment option. This breakthrough brings hope to individuals and families facing this condition, giving clinicians a novel therapy to address the unmet need in treatment. Bristol Myers Squibb is committed to advancing cardiovascular care for patients in India.”

Globally, mavacamten has been widely recognized, with its first approval granted by the U.S. Food and Drug Administration (FDA) on April 28, 2022, followed by approval from the European Union on June 26, 2023. Since then, the medicine has continued to expand its reach, receiving marketing authorization in more than 50 countries, underscoring its global significance as a breakthrough therapy for symptomatic obstructive hypertrophic cardiomyopathy. 

In two phase III clinical studies, mavacamten has shown a consistent efficacy and safety profile. Some of the patients experienced a transient drop in ejection fraction (the heart’s pumping ability); however, all patients recovered following interruption.

Bristol Myers Squibb has been present in India for over 20 years and is presently providing treatments in oncology and hematology. The introduction of Kopozgo in India marks an extension of Bristol Myers Squibb’s therapeutic offerings into cardiology. This development builds on the company’s strong presence in oncology and hematology, representing an expansion of its portfolio. BMS aims to offer best-in-class global treatments to patients in India and is committed to bringing more medicines to more patients faster.